[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573976":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":10,"responsibleParty":21,"collaborators":10,"id":25,"slug":26,"hasResults":27,"nctId":28,"briefTitle":29,"officialTitle":29,"acronym":10,"eligibilityCriteria":30,"healthyVolunteers":31,"sex":32,"minAge":10,"maxAge":10,"enrollmentInfo":33,"targetDuration":10,"studyType":36,"phases":10,"briefSummary":37,"conditions":38,"keywords":40,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"cases",null,"patients with MPNs according to the recent WHO classification",{"label":13,"type":10,"description":14,"interventionNames":10},"control","normal healthy individual",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Ola Gamal Taha Hussein, resident doctor","CONTACT","+201003196138","Ola.16266122@med.aun.edu.eg",{"type":22,"investigatorFullName":23,"investigatorTitle":24,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Ola Gamal Taha Hussein","resident doctor at Assiut University hospital","100573976","clinical-significance-of-leukocyte-cell-population-data-in-patients-with-myeloproliferative-neoplasms-mpns-100573976",false,"NCT06753279","Clinical Significance of Leukocyte Cell Population Data in Patients With Myeloproliferative Neoplasms (MPNs)","Inclusion Criteria:\n\n* Patients with MPNs according to the recent WHO classification.\n\nExclusion Criteria:\n\n* Patients with other types of myeloid neoplasms and\u002For not fulfil the WHO criteria for MPNs diagnosis.",true,"ALL",{"count":34,"type":35},80,"ESTIMATED","OBSERVATIONAL","Myeloproliferative neoplasms (MPNs) are a group of clonal hematopoietic disorders which categorized according to the World Health Organization (WHO) into Philadelphia Chromosome positive (Ph +ve) including chronic myeloid leukemia (CML) and Philadelphia Chromosome negative (Ph -ve) like essential thrombocythemia (ET), polycythaemia vera (PV), and primary myelofibrosis (PMF) .\n\nthe aim of the study is to Detection of leukocyte cell population data in patients with MPNs and Relation between leukocyte cell population and patients' clinical status.",[39],"Myeloproliferative Neoplasms (MPNs)",[41],"leukocyte cell","NOT_YET_RECRUITING","2024-12-22",{"date":45,"type":46},"2024-12-31","ACTUAL",{"date":48,"type":35},"2025-01-01",{"date":50,"type":35},"2026-03-01",{"name":5,"class":6}]